LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this investigation is to establish the safety and effectiveness of the LDR Spine Mobi-C® Cervical Disc Prosthesis which is an anterior cervical interbody mechanical device. The primary objective of the study is to evaluate the overall success rate of the investigational device as compared to the control in the treatment of patients with symptomatic DDD with radiculopathy or myeloradiculopathy at one or two adjacent levels. Patients should be without prior cervical fusion between C3 and C7 and unresponsive to non-operative conservative treatment for six weeks after symptom onset or have the presence of progressive symptoms or signs of nerve/spinal cord compression despite continued non-operative conservative treatment.
| Condition | Intervention | Phase |
|---|---|---|
|
Degenerative Disc Disease |
Device: Cervical Artificial Disc |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE |
- Composite definition of Study Success [ Time Frame: 2 Years ] [ Designated as safety issue: Yes ]
| Enrollment: | 600 |
| Study Start Date: | April 2006 |
| Estimated Study Completion Date: | March 2018 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1 Level Use
Use of the Investigational Device compared to standard of care, for treatement at 1 cervical spine level.
|
Device: Cervical Artificial Disc
Cervical artificial disc mechanical device
|
|
Experimental: 2Level
Use of the Investigational Device compared to standard of care for 2 cervical spine levels.
|
Device: Cervical Artificial Disc
Cervical artificial disc mechanical device
|
Detailed Description:
Objectives of the Investigation
The purpose of this investigation is to establish the safety and effectiveness of the LDR Spine Mobi-C® Cervical Disc Prosthesis which is an anterior cervical interbody mechanical device. The primary objective of the study is to evaluate the overall success rate of the investigational device as compared to the control in the treatment of patients with symptomatic DDD with radiculopathy or myeloradiculopathy at one or two adjacent levels. Patients should be without prior cervical fusion between C3 and C7 and unresponsive to non-operative conservative treatment for six weeks after symptom onset or have the presence of progressive symptoms or signs of nerve/spinal cord compression despite continued non-operative conservative treatment.
A maximum of 25 centers will participate in the study. Enrollment will be monitored to ensure that each center performs an adequate number of cases and no one center contributes a disproportionate number of cases to optimize poolability.
Study Design Rationale
The study is a prospective, randomized, multi-center, concurrently controlled investigation, in which the study device will be compared to the control treatment consisting of conventional anterior cervical discectomy and fusion (ACDF) in accordance with the Smith-Robinson procedure. Patients will be followed for two years postsurgery (primary endpoint) and annually thereafter.
Duration of the Investigation
Patients will be followed post-operatively at 6 weeks, and 3-, 6-, 12-, 18-, and 24-months. After 24 months, patients will continue to be followed annually.
Design Techniques to Avoid Bias
To eliminate selection bias, investigational and control comparison groups will be assigned at random.
Institutional Review Board
No clinical studies will begin without documented approval of the clinical investigation by the Institutional Review Board (IRB) affiliated with the study center.
Eligibility| Ages Eligible for Study: | 18 Years to 69 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 18-69 years.
Diagnosis of radiculopathy or myeloradiculopathy of the cervical spine, with pain, paresthesias or paralysis in a specific nerve root distribution C3 through C7, including at least one of the following:
- Neck and/or arm pain (at least 30mm on the 100mm VAS scale).
- Decreased muscle strength of at least one level on the clinical evaluation 0 to 5 scale.
- Abnormal sensation including hyperesthesia or hypoesthesia; and/or
- Abnormal reflexes
- Symptomatic at one or two adjacent levels from C3 to C7;
Radiographically determined pathology at one or two adjacent level(s) to be treated correlating to primary symptoms including at least one of the following:
- Decreased disc height on radiography, CT, or MRI in comparison to a normal adjacent disc.
- Degenerative spondylosis on CT or MRI.
- Disc herniation on CT or MRI;
- Neck Disability Index Score of ≥15/50 or ≥30%;
Unresponsive to non-operative, conservative treatment (rest, heat, electrotherapy, physical therapy, chiropractic care and/or analgesics) for:
- Approximately six weeks from radiculopathy or myeloradiculopathy symptom onset; or
- Have the presence of progressive symptoms or signs of nerve root/spinal cord compression despite continued non-operative conservative treatment.
Note: Not a complete listing
Exclusion Criteria:
- Reported to have an active systemic infection or infection at the operative site;
- Reported to have a history of or anticipated treatment for active systemic infection, including HIV or Hepatitis C;
- More than one immobile vertebral level between C1 to C7 from any cause including but not limited to congenital abnormalities and osteoarthritic "spontaneous" fusions;
- Previous trauma to the C3 to C7 levels resulting in significant bony or disco-ligamentous cervical spine injury;
- Reported to have had any prior spine surgery at the operative level;
- Reported to have had prior cervical fusion procedure at any level;
- Axial neck pain in the absence of other symptoms of radiculopathy or myeloradiculopathy justifying the need for surgical intervention;
- Disc height less than 3mm as measured from the center of the disc in a neutral position and disc height less than 20% of the anterior-posterior width of the inferior vertebral body;
- Radiographic confirmation of severe facet joint disease or degeneration;
Note: Not a complete listing
Contacts and Locations| United States, Arizona | |
| Texas Back Institute-West | |
| Phoenix, Arizona, United States, 85015 | |
| United States, California | |
| Southern California Institute of Neurological Surgery | |
| Escondido, California, United States, 92122 | |
| Massoudi & Jackson Neurosurgical Association | |
| Laguna Hills, California, United States, 92653 | |
| Memorial Orthopaedic Surgical Group | |
| Long Beach, California, United States, 90806 | |
| Eisenhower Medical Center | |
| Rancho Mirage, California, United States, 92270 | |
| University of California- Davis Medical Center | |
| Sacramento, California, United States, 95817 | |
| Spine Institute at St. John's Health Center | |
| Santa Monica, California, United States, 90404 | |
| Stanford University | |
| Stanford, California, United States, 94305 | |
| United States, Colorado | |
| Panorama Orthopedics and Spine Care | |
| Golden, Colorado, United States, 80401 | |
| United States, Florida | |
| Southeastern Clinical Research | |
| Orlando, Florida, United States, 32804 | |
| United States, Indiana | |
| Orthopaedics North East | |
| Fort Wayne, Indiana, United States, 46825 | |
| United States, Louisiana | |
| Spine Institute of Louisiana | |
| Shreveport, Louisiana, United States, 71101 | |
| United States, Maryland | |
| GBMC Healthcare | |
| Baltimore, Maryland, United States, 21204 | |
| United States, Michigan | |
| University Neurologic Systems | |
| Detroit, Michigan, United States, 48201 | |
| St. Mary's of Saginaw Field Neurosciences Institute | |
| Saginaw, Michigan, United States, 48604 | |
| United States, New York | |
| Simmons Orthopaedics and Spine Associates | |
| Buffalo, New York, United States, 14201 | |
| Orthopedic Spine Care of Long Island | |
| Melville, New York, United States, 11747 | |
| United States, Ohio | |
| The Cleveland Clinic | |
| Cleveland, Ohio, United States, 44195 | |
| United States, Oklahoma | |
| Oklahoma Spine & Brain Institute | |
| Tulsa, Oklahoma, United States, 74132 | |
| United States, Texas | |
| Austin Brain and Spine | |
| Austin, Texas, United States, 78701 | |
| Foundation Surgical Hospital | |
| Houston, Texas, United States, 77401 | |
| West Texas Spine | |
| Odessa, Texas, United States, 79761 | |
| Texas Back Institute | |
| Plano, Texas, United States, 75093 | |
| Texas Spine and Joint Hospital | |
| Tyler, Texas, United States, 75701 | |
| Principal Investigator: | Ralph Rashbaum, MD | Texas Back Institute |
More Information
No publications provided
| Responsible Party: | LDR Spine USA |
| ClinicalTrials.gov Identifier: | NCT00389597 History of Changes |
| Other Study ID Numbers: | LDR-001, IDE Number G050212 |
| Study First Received: | October 18, 2006 |
| Last Updated: | October 14, 2012 |
| Health Authority: | United States: Food and Drug Administration |
Additional relevant MeSH terms:
|
Intervertebral Disk Degeneration Spinal Diseases Bone Diseases Musculoskeletal Diseases |
ClinicalTrials.gov processed this record on May 16, 2013